Gómez-Tortosa E, Gonzalo I, Fanjul S, Sainz MJ, Cantarero S, Cemillán C, Yébenes JG, del Ser T. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease. Arch Neurol. 2003 Sep;60(9):1218-22. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)		 Cohort
(N)		 Measurement
Mean ± SD		 Method;
Assay Name;
Manufacturer		 Diagnostic
Criteria
Aβ42
(CSF)		 AD
(33)		 348 ± 309
pg/mL		 ELISA;
Innotest;
Innogenetics		 McKhann et al., 1984
Aβ42
(CSF)		 CTRL-
Other Controls
(46)		 462 ± 352
pg/mL		 ELISA;
Innotest;
Innogenetics
Aβ42
(CSF)		 DLB
(25)		 320 ± 233
pg/mL		 ELISA;
Innotest;
Innogenetics		 McKeith et al., 1996
tau-total
(CSF)		 AD
(33)		 500 ± 399
pg/mL		 ELISA;
Innotest;
Innogenetics		 McKhann et al., 1984
tau-total
(CSF)		 CTRL-
Other Controls
(46)		 200 ± 243
pg/mL		 ELISA;
Innotest;
Innogenetics
tau-total
(CSF)		 DLB
(25)		 213 ± 243
pg/mL		 ELISA;
Innotest;
Innogenetics		 McKeith et al., 1996

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Biomarker Bonus: Phospho-Tau/Aβ Ratio Increase Sensitivity

AlzBiomarker

  1. AD vs CTRL : Aβ42 (CSF)
  2. CTRL vs AD : Aβ42 (CSF)
  3. DLB vs AD : Aβ42 (CSF)
  4. AD vs CTRL : tau-total (CSF)
  5. CTRL vs AD : tau-total (CSF)
  6. DLB vs AD : tau-total (CSF)